Robert Hromas

14.6k total citations · 2 hit papers
207 papers, 10.4k citations indexed

About

Robert Hromas is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Robert Hromas has authored 207 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 70 papers in Oncology and 44 papers in Immunology. Recurrent topics in Robert Hromas's work include DNA Repair Mechanisms (69 papers), Epigenetics and DNA Methylation (26 papers) and Acute Myeloid Leukemia Research (23 papers). Robert Hromas is often cited by papers focused on DNA Repair Mechanisms (69 papers), Epigenetics and DNA Methylation (26 papers) and Acute Myeloid Leukemia Research (23 papers). Robert Hromas collaborates with scholars based in United States, France and China. Robert Hromas's co-authors include Daniel G. Tenen, Dong‐Er Zhang, Jonathan D. Licht, Hal E. Broxmeyer, Jac A. Nickoloff, Elizabeth A. Williamson, M Klemsz, Suk‐Hee Lee, Michael J. Robertson and Kent W. Christopherson and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert Hromas

204 papers receiving 10.2k citations

Hit Papers

Transcription Factors, No... 1997 2026 2006 2016 1997 1997 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Hromas 6.1k 2.7k 2.7k 1.6k 1.2k 207 10.4k
Ilan R. Kirsch 5.7k 0.9× 3.7k 1.4× 2.3k 0.8× 1.9k 1.1× 1.6k 1.3× 141 11.8k
Atsushi Iwama 7.6k 1.2× 2.2k 0.8× 2.5k 0.9× 3.6k 2.2× 804 0.7× 251 12.1k
Martin J.S. Dyer 6.3k 1.0× 4.6k 1.7× 4.9k 1.8× 2.1k 1.3× 768 0.6× 300 16.5k
Albert F. LoBuglio 3.6k 0.6× 2.9k 1.1× 3.0k 1.1× 892 0.5× 867 0.7× 189 9.5k
Ashley R. Dunn 3.6k 0.6× 2.0k 0.7× 4.9k 1.8× 1.1k 0.7× 1.1k 0.9× 101 10.0k
Ivan Maillard 3.7k 0.6× 1.5k 0.6× 2.7k 1.0× 1.2k 0.7× 540 0.4× 152 8.1k
Iannis Aifantis 7.5k 1.2× 2.7k 1.0× 3.5k 1.3× 2.0k 1.2× 633 0.5× 155 11.9k
Bruno Calabretta 8.6k 1.4× 2.6k 1.0× 1.6k 0.6× 3.4k 2.1× 1.1k 0.9× 237 13.2k
Hisamaru Hirai 9.1k 1.5× 3.2k 1.2× 3.6k 1.4× 3.8k 2.3× 1.1k 0.9× 302 17.1k
Helmut Hanenberg 6.0k 1.0× 2.0k 0.8× 1.6k 0.6× 1.3k 0.8× 2.8k 2.3× 195 9.4k

Countries citing papers authored by Robert Hromas

Since Specialization
Citations

This map shows the geographic impact of Robert Hromas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hromas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hromas more than expected).

Fields of papers citing papers by Robert Hromas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Hromas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hromas. The network helps show where Robert Hromas may publish in the future.

Co-authorship network of co-authors of Robert Hromas

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Hromas. A scholar is included among the top collaborators of Robert Hromas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Hromas. Robert Hromas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zheng‐Yu, Bo‐Syong Pan, Rajesh Manne, et al.. (2025). CD36-mediated endocytosis of proteolysis-targeting chimeras. Cell. 188(12). 3219–3237.e18. 15 indexed citations
2.
He, Yonghan, Chunbao Sun, Peiyi Zhang, et al.. (2025). A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice. Nature Aging. 5(3). 386–400. 10 indexed citations
3.
Jaiswal, Aruna S., Arijit Dutta, Gayathri Srinivasan, et al.. (2023). TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. Nucleic Acids Research. 51(22). 12224–12241. 10 indexed citations
4.
Nickoloff, Jac A., Aruna S. Jaiswal, Neelam Sharma, et al.. (2023). Cellular Responses to Widespread DNA Replication Stress. International Journal of Molecular Sciences. 24(23). 16903–16903. 15 indexed citations
5.
Rawal, Yashpal, Shuo Zhou, Hardeep Kaur, et al.. (2023). Structural insights into BCDX2 complex function in homologous recombination. Nature. 619(7970). 640–649. 22 indexed citations
6.
Jaiswal, Aruna S., Orlando D. Schärer, Neelam Sharma, et al.. (2023). EEPD1 promotes repair of oxidatively-stressed replication forks. NAR Cancer. 5(1). zcac044–zcac044. 8 indexed citations
7.
Yadav, Pooja, Panneerdoss Subbarayalu, Saif Nirzhor, et al.. (2022). M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression. Cancer Research. 82(10). 1872–1889. 59 indexed citations
8.
Kornepati, Anand, Clare Murray, Cody M. Rogers, et al.. (2022). Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor–Induced Synthetic Lethality. Cancer Research. 82(11). 2156–2170. 39 indexed citations
9.
Thummuri, Dinesh, Sajid Khan, Patrick W. Underwood, et al.. (2021). Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216. Molecular Cancer Therapeutics. 21(1). 184–192. 51 indexed citations
10.
He, Yonghan, Sajid Khan, Zhiguang Huo, et al.. (2020). Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. Journal of Hematology & Oncology. 13(1). 103–103. 86 indexed citations
11.
Fletcher-Sananikone, Eliot, Bipasha Mukherjee, Rahul K. Kollipara, et al.. (2019). Radiation-Induced DNA Damage Cooperates with Heterozygosity of TP53 and PTEN to Generate High-Grade Gliomas. Cancer Research. 79(14). 3749–3761. 24 indexed citations
12.
Shao, Lijian, Jianhui Chang, Wei Feng, et al.. (2018). The Wave2 scaffold Hem-1 is required for transition of fetal liver hematopoiesis to bone marrow. Nature Communications. 9(1). 2377–2377. 12 indexed citations
13.
Nickoloff, Jac A., Dennie V. Jones, Suk‐Hee Lee, Elizabeth A. Williamson, & Robert Hromas. (2017). Drugging the Cancers Addicted to DNA Repair. PMC. 3 indexed citations
14.
Williamson, Elizabeth A., Leah A. Damiani, Andrei Leitão, et al.. (2012). Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy. Cancer Research. 72(23). 6200–6208. 30 indexed citations
15.
Williamson, Elizabeth A., Justin Wray, Pranshu Bansal, & Robert Hromas. (2012). Overview for the Histone Codes for DNA Repair. Progress in molecular biology and translational science. 110. 207–227. 41 indexed citations
16.
Beck, Brian D., et al.. (2010). Regulation of Metnase’s TIR binding activity by its binding partner, Pso4. Archives of Biochemistry and Biophysics. 498(2). 89–94. 14 indexed citations
17.
Kong, Kimi, et al.. (2009). Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4. Blood. 114(1). 60–63. 7 indexed citations
18.
Blanke, Charles D., Cari J. Clark, Guido Tricot, et al.. (1995). Evolving pathogens in allogeneic bone marrow transplantation: Increased fatal adenoviral infections. The American Journal of Medicine. 99(3). 326–328. 73 indexed citations
19.
Hromas, Robert, et al.. (1990). Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer. Nucleic Acids Research. 18(4). 1037–1043. 32 indexed citations
20.
Hromas, Robert, Bart Barlogie, & R.E. Meyn. (1985). Diverse mechanisms and methods of overcoming cis-platinum resistance in L1210 leukemia cells. Proceedings of the American Association for Cancer Research. 26. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026